![](https://s.turbifycdn.com/aah/yhst-15683259105916/farm-ranch-54.gif) | ![](https://sep.turbifycdn.com/ca/Img/trans_1x1.gif) | ![](https://s.turbifycdn.com/aah/yhst-15683259105916/farm-ranch-55.gif)
![Click to enlarge](https://s.turbifycdn.com/aah/yhst-15683259105916/pneumostar-myco-37.gif) ![](https://sep.turbifycdn.com/ca/Img/trans_1x1.gif) ![PneumoSTAR Myco](https://s.turbifycdn.com/aah/yhst-15683259105916/pneumostar-myco-38.gif)
NOVARTIS
PRODUCT DISCONTINUED BY MANUFACTURER
A killed vaccine offering one-shot, one-mL protection against mycoplasmal pneumonia in an easily syringeable formulation. The product contains the proprietary ImmunSTAR adjuvant technology that makes the product efficacious at a low dose level. This technology also is the basis of another new one-shot, one-mL swine vaccine introduced by Novartis recently – PneumoSTAR SIV.
Research conducted to receive USDA approval showed the mycoplasmal pneumonia vaccine to be effective for 23 weeks following administration. In a controlled study, animals challenged 23 weeks after a single 1-mL vaccination of PneumoSTAR Myco had a 50 percent reduction in lung lesions at slaughter compared to nonvaccinated controls.
DOSAGE/ADMINISTRATION:
3 weeks of age or older. 1 mL dose, intramuscularly.
|
Please contact us for discount pricing on large orders.
Call toll free 1-800-892-6978
or email us at info@animalhealthusa.com |
|